Key takeaways from Advanced Therapies Europe
Read MoreCellular Origins and 3P innovation collaborate to accelerate industrialisation of CGT manufacturing
Read MoreCellular Origins Appoints Geoffrey Hodge as Non-Executive Director
Read MoreCellular Origins Acquires ACTIA Platform IP to enhance automated cell therapy manufacturing
Read MoreCellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing
Read MoreISCT Vancouver 2024
Read MoreACHEMA 2024
Read MoreMeet Szer Ming Lee, Head of Software at Cellular Origins
Read MoreCellular Origins awarded highly commended in ‘The Award for Innovation’ at this year’s Cambridge Independent Science and Technology Awards
Read MoreCellular Origins, a TTP Company, appoints Peter Crossley as Chief Operating Officer
Read MoreMeet Jason Jones, Global Business Development Lead at Cellular Origins
Read MoreCellular Origins, a TTP Company, establishes Advisory Board of global industry leaders
Read MoreAdvanced Therapies Week 2024
Read MoreKeeping Up with the Pace in a Rapidly Changing Industry: Innovative Solutions for Cell and Gene Therapy Developers
Read MoreDrug Digest: Improving Aseptic Processing and Manufacturing Needs
Read MoreBioPharm International: Automation Aids Cell and Gene Therapy Production
Read MoreBioPharm International: Expanding the Emerging Therapeutic Horizon
Read MoreAdvanced Therapies Week: Building Infrastructure and Capacity Panel Session
Read MoreCellular Origins launches Constellation™, its configurable robotic platform to enable scalable manufacture of advanced therapies
Read MoreISCT 2023 Paris Annual Meeting
Read MoreCellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing
Read MoreLabiotech: Where is innovation needed in cell therapy?
Read MoreBeyond Biotech podcast 36: Bio-Europe Spring and Cellular Origins
Read MoreConstellation featured in Science: Configurable Robotic Platform For Advanced Therapy Manufacturing
Read MoreGEN: Cell and Gene Therapy Scale-Up Challenges
Read MoreNo More Sleepwalking: New Mindsets for Manufacturing Cell and Gene Therapies at Commercial Scale
Read MoreTTP introduces cellular origins a TTP company focussed on delivering scalable manufacture of cell and gene therapies
Read MoreWhat failure rate are we willing to accept in cell therapy manufacture? Insights from medical device development
Read MoreUK Innovation corridor ‘critical’ to development of cell and gene therapy, TTP plc summit told
Read MoreVideo Interview: Talking Cell Therapy Trends – Edd Stone of TTP explains how the industry is overcoming the manufacturing challenges associated with cell therapies
Read MoreMedicine Maker: How do we ensure that not only the rich benefit from cell and gene therapy?
Read MoreWhat can our experience of traditional bioprocessing teach us about the manufacturing of new cell therapies?
Read MorePredicting failure rates in cell therapy manufacturing is one in a million good enough
Read MoreGEN: Technological Advances Facilitate Autologous Cell Therapy Scale-Out
Read MoreWho should lead the charge in cell therapy manufacturing
Read MoreCell therapy scaling beyond the biology
Read MoreAs featured in:
Sign up for updates.
Stay up-to-date with Cellular Origins and our modular factory automation for cell and gene therapies.